|
|
|
|
|
|
|
|
|
Bortezomib, Velcade Description Bortezomib is the first drug approved of anticancer agents known as proteasome inhibitors. Action anti-cancer, proteasome inhibitors Indications Cancer Side Effects Common adverse effects include nausea, fatigue, diarrhea, constipation, headache, decreased appetite, thrombocytopenia, anemia, fever, vomiting, or peripheral neuropathy; may cause hypotension; caution with hepatic impairment; at least 72 h should elapse between each dose Drug-Vitamin-Herb Interactions
|
Fantastic new books! CAM Therapies has studies on natural therapies for over 100 diseases. CAM Labs lists lab tests for 100 diseases. Nutritional Genetics is a fantastic resource.
|
©